General Electric has been accused of failing to adequately inform Danish regulators about a patient who died after being exposed to a gadolinium-based MRI contrast agent.

According to the Danish Medicines Agency, Birthe Madsen was given an Omniscan for an MRI in 2002 and she is now believed to be one of the first patients to have developed nephrogenic systemic fibrosis. In 2004, a government agency found that Omniscan was responsible for Madsen's condition and her death.

GE Healthcare was reportedly notified of the decision but did not immediately report the incident to the Danish Medicines Agency. The company, however, will not face any further action related to Madsen's death because the statute of limitations has expired.

GE denies that Omniscan causes nephrogenic systemic fibrosis.

If you have developed NSF because of gadolinium-based agents, you may be eligible for compensation. Contact a gadolinium attorney of Williams Kherkher by calling 800-761-3187.